Product Highlight Announcement
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel. This designation certifies that the DRG ELISA meets the performance target set by DEQAS for 25 Hydroxyvitamin D.
DRG is committed to bringing to market the best, most accurate tests, and as such, we would like to present the specifications and indications of our 25-OH Vitamin D total ELISA (EIA-5396) testing kit.
Vitamin D deficiency is a serious issue that can affect people at any age. Without enough sunlight and dietary Vitamin D, children may be at greater risk for rickets and adults may be at greater risk for osteoporosis. While issues in bone development and strength are what first come to mind with Vitamin D deficiency, it has been shown that it may raise the risk of high blood pressure and type 2 diabetes.
Beyond the most commonly studied effects of Vitamin D deficiency, there are a wide-range of other health issues that are currently being researched as being directly impacted by Vitamin D deficiency and lack of absorption, including:
- Some types of cancer
- Hypertension (high blood pressure)
- Autoimmune conditions (such as lupus, ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis)
- PCOS (polycystic ovarian syndrome)
- Diabetes mellitus (both types 1 and 2)
DRG offers the 25-OH Vitamin D total ELISA (EIA-5396), approved for laboratory research use only in the United States, and is not for use in diagnostic or therapeutic procedures. However, this product has received its CE Mark.
This DRG Elisa is an enzyme immunoassay for measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in serum and plasma.
Specifications of the product include:
- Serum/ Plasma testing
- Only 25 uL sample required
- Kit-internal controls
- Wells single-breakable
- Very simple assay procedure
- 105 min incubation time
- No extraction step required
Latest posts by Gregory C. Guest (see all)
- DRG SUCCESSFULLY EXHIBITS AT MEDLAB DUBAI 2018! - February 28, 2018
- DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil - November 22, 2017
- DRG´s Newly Optimized Salivary Testosterone Kit used in New Study! - September 18, 2017
News and Updates
The DRG Group recently exhibited at the largest healthcare exhibition & congress in the Middle East: MEDLAB DUBAI from February 5 - 8, 2018 with great success! In addition to the presentation of several new assays DRG offered live demonstrations of our...read more
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...read more
New Poster presented using DRG´s newly optimized Salivary Testosterone Kit Ellie Shuo Jin, Doctoral Candidate in Clinical Psychology of the University of Texas at Austin, presented her poster at the Meeting of International Society of Psychoneuroendocrinology...read more